Aging rewrites the controls. Some of the rewrite can be undone

A hundred thousand switches flip on

In a preprint on cardiac aging, aging produced a large shift in the heart's regulatory landscape, characterised by the activation of over 100,000 latent enhancers driven by AP-1. These enhancers showed low baseline accessibility but high transcriptional potential, meaning they were mostly quiet in younger tissue yet capable of strong activity once switched on, and they were sensitive to IL-1 signaling. m:…1586

The scale is the story. This is not a handful of genes drifting with age but a broad regulatory state that the aged heart acquires, with AP-1 as a driver and IL-1 signaling as a sensitivity. That breadth is also what makes the next finding notable: a state acquired broadly may be a state that can be shifted broadly. m:…1586

Exercise reverses the state

The same preprint reports that endurance exercise and pharmacological AP-1 inhibition can reverse these age-acquired regulatory states. The authors present this as a mechanistic basis for the protective effects of exercise on the aging heart, and they identify AP-1 and IL-1 as potential therapeutic targets for mitigating cardiac aging. m:…1586

Reversal here means the regulatory state, not the age of the animal. The preprint does not claim that exercise makes an old heart young, and it does not report human outcomes. What it offers is a mechanism: if exercise protects the aging heart, part of how it does so may run through these enhancers and their drivers. m:…1586

What reversal does and does not show

It is worth being precise about what reversal means in these preprints. The cardiac preprint identifies AP-1 and IL-1 as potential therapeutic targets, which is a statement about where to look next, not a treatment. The skin preprints likewise identify targets for dermatological development and chronic wound management. None of them reports a therapy tested in people. m:…1586 m:…8928 m:…7829

Not every mark behaves the same

The remaining preprints also name their next steps in concrete terms. The cardiac preprint reports that endurance exercise reverses the majority of age-acquired enhancer gains, and that the age-gained enhancers respond to neutralisation of IL-1 in vivo. The glycogene preprint names integrins, junctional proteins and surface receptors as candidate proteins regulated by St6gal1 and Man1a, and the wound preprint reports that local delivery of IGFBP2 accelerates wound closure in diabetic mice. m:…1586 m:…8928 m:…7829

Two preprints on skin point in a similar direction, that specific age-related changes can be traced to specific regulators. In aged mouse skin, two glycogenes are upregulated, and inducible transgenic models showed distinct effects: Man1a overexpression reduced epidermal proliferation and thickness, while St6gal1 overexpression drove systemic splenomegaly and skin inflammation. The authors link specific glycosylation changes to age-related epidermal dysfunction and flag them as potential dermatological targets. m:…8928

A third preprint finds a fat-to-skin signal with the opposite sign. Adipocyte Kindlin-2 acts as a negative regulator of skin regeneration, and its loss in adipocytes leads to E-cadherin proteolysis, releasing a signaling fragment that activates beta-catenin and upregulates IGFBP2. The secreted IGFBP2 promoted wound healing, including in diabetic mouse models, and the authors present Kindlin-2 as a target for chronic wound management. m:…7829

Read together, the three preprints describe aging less as uniform wear and more as a set of regulatory states, some reversible, some pre-existing, some tunable through a single signaling axis. All three are preprints based largely on animal and organoid models, so human relevance, durability and safety remain open. m:…1586 m:…8928 m:…7829